#JPM20 ex­clu­sive: Olivi­er Brandi­court fol­lows the Big Phar­ma CEO path to pri­vate eq­ui­ty, join­ing Black­stone ahead of a mam­moth fund de­but

Nick Galakatos Black­stone

Sev­en months af­ter Olivi­er Brandi­court’s sur­prise “ear­ly re­tire­ment” from Sanofi, he’s back in the game, this time tak­ing meet­ings at JP Mor­gan to dis­cuss his new role at Black­stone, where he’s qui­et­ly be­gun work with Nick Galakatos and the life sci­ences crew.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER